Product Data Sheet

RA-263

Catalog No. A56373

main product photo
RA-263 is a 2-nitroimidazole nucleoside that functions as a radiosensitizer. This compound enhances the efficacy of radiation therapy by increasing the sensitivity of tumor cells to ionizing radiation. RA-263 is primarily utilized in cancer research to investigate combined modality treatments and to explore mechanisms of radioresistance in various tumor models.
Chemical Information
Catalog NumA56373
M. Wt241.20
FormulaC9H11N3O5
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.82205-95-6
Synonyms
SMILESOC1C(CO)OC(N2C=CN=C2[N+]([O-])=O)C=C1
Biological Activity
DescriptionRA-263 is a 2-nitroimidazole nucleoside that functions as a radiosensitizer. This compound enhances the efficacy of radiation therapy by increasing the sensitivity of tumor cells to ionizing radiation. RA-263 is primarily utilized in cancer research to investigate combined modality treatments and to explore mechanisms of radioresistance in various tumor models.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.